MIRA INFORM REPORT
|
Report No. : |
307747 |
|
Report Date : |
12.02.2015 |
IDENTIFICATION DETAILS
|
Name : |
KOPRAN LIMITED |
|
|
|
|
Registered
Office : |
Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400018,
Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2014 |
|
|
|
|
Date of
Incorporation : |
26.04.1958 |
|
|
|
|
Com. Reg. No.: |
11-011078 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.476.289 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
L24230MH1958PLC011078 |
|
|
|
|
IEC No.: |
Not Available |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMK01878C |
|
|
|
|
PAN No.: [Permanent Account No.] |
Not Available |
|
|
|
|
Legal Form : |
A Public Limited Liability Company. The Company’s Shares are Listed on
the Stock Exchanges. |
|
|
|
|
Line of Business
: |
Manufactures and sells pharmaceutical products. |
|
|
|
|
No. of Employees
: |
Information declined by the management. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track record. General financial position of the company is good. Trade relations are reported as fair. Business is active. Payments
terms are reported to be usually correct. The company can be considered for normal for business dealings at
usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
Long term rating: BBB- |
|
Rating Explanation |
Moderate degree of safety it carry moderate credit risk. |
|
Date |
23rd January 2015 |
|
Rating Agency Name |
CRISIL |
|
Rating |
Short term rating: A3 |
|
Rating Explanation |
Moderate degree of safety it carry higher credit risk. |
|
Date |
23rd January 2015 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION DENIED BY
MANAGEMENT NON – COOPERATIVE (91-22-43661111)
LOCATIONS
|
Registered Office : |
Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400018, Maharashtra, India |
|
Tel. No.: |
91-22-24964480-85/ 43661111 |
|
Fax No.: |
91-22-24950363 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory 1 : |
Formulation Unit Village Savroli, Taluka Khalapur, Khopoli, District Raigad
– 410202, Maharashtra, India |
|
Tel. No : |
91-2192-274500 |
|
Fax No : |
91-2192-274025 |
|
|
|
|
Factory 2 : |
API
Unit
K-4, Additional MIDC, Village Birwadi, Mahad – 403201 District Raigad, Maharashtra, India |
|
Tel. No : |
91-2145-251101-04 |
|
Fax No : |
91-2145-251100 |
DIRECTORS
As on 31.03.2014
|
Name : |
Mr. V. N. Khanna |
|
Designation : |
Chairman |
|
|
|
|
Name : |
Mr. Susheel G. Somani |
|
Designation : |
Director |
|
Qualification : |
MSC |
|
|
|
|
Name : |
Mr. Surendra Somani |
|
Designation : |
Executive Vice-Chairman |
|
|
|
|
Name : |
Dr. A. K. Mehta |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. Ajit Jain |
|
Designation : |
Executive Director and Chief Operating Officer |
|
Qualification : |
FCA |
|
|
|
|
Name : |
Mr. Amit Rajan |
|
Designation : |
Director |
|
Qualification : |
M. Tech, (I.I.T. Delhi) |
|
|
|
|
Name : |
Mr. Vijay Kumar Bhandari |
|
Designation : |
Director |
|
Qualification : |
B.Com(Hons), FCA |
KEY EXECUTIVES
|
Name : |
Mr. Sunil Sodhani (Appointed w.e.f.28th May,2014) |
|
Designation : |
Company Secretary |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 31.12.2014
|
Category of
Shareholder |
No. of Shares |
% of holdings |
|
(A) Shareholding
of Promoter and Promoter Group |
||
|
|
|
|
|
|
5522700 |
13.44 |
|
|
11823313 |
28.77 |
|
|
17346013 |
42.20 |
|
|
|
|
|
Total
shareholding of Promoter and Promoter Group (A) |
17346013 |
42.20 |
|
(B) Public
Shareholding |
||
|
|
|
|
|
|
28890 |
0.07 |
|
|
1158956 |
2.82 |
|
|
300 |
0.00 |
|
|
1188146 |
2.89 |
|
|
|
|
|
|
3828635 |
9.32 |
|
|
|
|
|
|
13093663 |
31.86 |
|
|
4839582 |
11.78 |
|
|
803437 |
1.95 |
|
|
5700 |
0.01 |
|
|
238643 |
0.58 |
|
|
559094 |
1.36 |
|
|
22565317 |
54.90 |
|
Total Public
shareholding (B) |
23753463 |
57.80 |
|
Total (A)+(B) |
41099476 |
100.00 |
|
(C) Shares held
by Custodians and against which Depository Receipts have been issued |
|
|
|
|
0 |
0.00 |
|
|
0 |
0.00 |
|
|
0 |
0.00 |
|
Total
(A)+(B)+(C) |
41099476 |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufactures and sells pharmaceutical products. |
|
|
|
|
Products : |
Not Available |
|
|
|
|
Brand Names : |
Not Available |
|
|
|
|
Agencies Held : |
Not Available |
|
|
|
|
Exports : |
Not Available |
|
|
|
|
Imports : |
Not Available |
|
|
|
|
Terms : |
|
|
Selling : |
Not Available |
|
|
|
|
Purchasing : |
Not Available |
GENERAL INFORMATION
|
Suppliers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Customers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
No. of Employees : |
Information declined by the management. |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Bankers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Facilities : |
|
|||||||||||||||||||||||||||
|
|
|
|
Auditors : |
|
|
Name : |
Batliboi and Purohit Chartered Accountants |
|
Address : |
Mumbai, Maharashtra, India |
|
|
|
|
Secretarial auditors: |
GMJ and Associates Practicing Company Secretaries |
|
|
|
|
Internal auditors: |
NGS and Company. LLP, Chartered Accountants |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Wholly Owned Subsidiary : |
·
Kopran Research Laboratories Limited ·
Kopran (H.K) Limited ·
Kopran Lifesciences Limited |
CAPITAL STRUCTURE
As on 31.03.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
56250000 |
Equity Shares |
Rs.10/- each |
Rs.562.500 Millions |
|
13750000 |
10% Non-convertible Non-cumulative redeemable preference shares |
Rs.10/- each |
Rs.137.500 Millions |
|
|
|
|
|
|
|
Total
|
|
Rs.700.000
Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
39052602 |
Equity Shares |
Rs.10/- each |
Rs.390.526 Millions |
|
8580000 |
10% Non-convertible Non-cumulative redeemable preference shares |
Rs.10/- each |
Rs.85.800 Millions |
|
|
Less: Calls in-Arrears (Other than Director's) |
|
Rs.0.037 Million |
|
|
|
|
|
|
|
Total |
|
Rs.476.289 Millions |
Note:
a) Terms / Rights
attached to equity Shares
The Company has only one class of equity shares having a par value of Rs.10/- per share. Each holder of equity shares is entitled to one vote per share. The Company declares and pays dividends in Indian rupees.
In the event of liquidation of the Company, the holders of equity shares will be entitled to receive remaining assets of the company, after distribution of all preferential amounts. The distribution will be in the proportion to the number of equity shares held by the shareholders.
b) Terms of
redemption of preference shares
55,80,000 10% Non-convertible non-cumulative redeemable preference shares of Rs. 10 each are redeemable at par on 15th March, 2025 or at any time after one year from 31st March, 2012 at the option of the company.
10,00,000 10% Non-convertible non-cumulative redeemable preference Shares of Rs. 10 each are redeemable at par on 28th June, 2019 or at any time after one year from 31st March, 2012 at the option of the company.
20,00,000 10% Non-convertible non-cumulative redeemable Preference Shares of Rs. 10 each are redeemable at par on 22nd June, 2019 or at any time after one year from 31st March, 2012 at the option of the company.
c) Shares held by
holding/ultimate holding company and/or their subsidiaries/associates
None of the shares of the Company are held by the subsidiaries, associates or joint ventures of the company.
d) Details of
shareholders holding more than 5% shares in the company
|
Particular |
As at 31st March, 2014 |
|
|
Equity Shares of
Rs. 10/- each fully paid |
Number of Shares |
% holding |
|
Ponorama Finvest Private Limited |
3800000 |
9.73% |
|
Sarvamangal Mercantile Company Limited |
2902951 |
7.43% |
|
|
|
|
|
10% Non-convertible
non-cumulative redeemable preference shares of Rs.10 each |
|
|
|
Sarvamangal Mercantile Company Limited |
6380000 |
74.00% |
|
Kopran Laboratories Limited |
1000000 |
12.00% |
|
Susheel G. Somani and Mridula Somani |
1200000 |
14.00% |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES
OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
476.289 |
476.289 |
476.289 |
|
(b) Reserves & Surplus |
975.214 |
804.822 |
684.192 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
1451.503 |
1281.111 |
1160.481 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
632.270 |
694.819 |
645.862 |
|
(b) Deferred tax liabilities
(Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term provisions |
35.469 |
35.654 |
31.318 |
|
Total
Non-current Liabilities (3) |
667.739 |
730.473 |
677.180 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
522.660 |
243.734 |
311.253 |
|
(b) Trade payables |
354.880 |
468.333 |
417.092 |
|
(c) Other current liabilities |
291.765 |
205.583 |
226.914 |
|
(d) Short-term provisions |
1.435 |
1.190 |
1.149 |
|
Total
Current Liabilities (4) |
1170.740 |
918.840 |
956.408 |
|
|
|
|
|
|
TOTAL |
3289.982 |
2930.424 |
2794.069 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
1026.619 |
1061.800 |
1116.022 |
|
(ii) Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii) Capital work-in-progress |
8.393 |
9.268 |
0.000 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
68.710 |
68.710 |
68.710 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
583.121 |
559.664 |
543.149 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total
Non-Current Assets |
1686.843 |
1699.442 |
1727.881 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
530.226 |
367.405 |
351.470 |
|
(c) Trade receivables |
546.359 |
496.098 |
375.162 |
|
(d) Cash and cash equivalents |
45.415 |
36.327 |
95.155 |
|
(e) Short-term loans and
advances |
481.139 |
331.152 |
244.401 |
|
(f) Other current assets |
0.000 |
0.000 |
0.000 |
|
Total
Current Assets |
1603.139 |
1230.982 |
1066.188 |
|
|
|
|
|
|
TOTAL |
3289.982 |
2930.424 |
2794.069 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
SALES |
|
|
|
|
|
Income |
3019.566 |
2502.192 |
1989.054 |
|
|
Other Income |
13.395 |
17.198 |
55.624 |
|
|
TOTAL
(A) |
3032.961 |
2519.390 |
2044.678 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of materials consumed |
1874.962 |
1582.263 |
1194.559 |
|
|
Purchase of Traded goods |
57.807 |
0.039 |
4.273 |
|
|
Changes in inventories of finished goods and work in
progress |
(63.628) |
(40.806) |
69.834 |
|
|
Employee benefit expense |
229.588 |
204.824 |
175.196 |
|
|
Other expenses |
494.637 |
412.929 |
328.357 |
|
|
TOTAL
(B) |
2593.366 |
2159.249 |
1772.219 |
|
|
|
|
|
|
|
Less |
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION (C) |
439.595 |
360.141 |
272.459 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
144.602 |
118.758 |
96.627 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
294.993 |
241.383 |
175.832 |
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION (F) |
124.601 |
120.753 |
114.157 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX (E-F) (G) |
170.392 |
120.630 |
61.675 |
|
|
|
|
|
|
|
Less |
TAX
(I) |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX (G-I)
(J) |
170.392 |
120.630 |
61.675 |
|
|
|
|
|
|
|
|
EARNINGS
IN FOREIGN CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
2056.047 |
1833.710 |
1235.200 |
|
|
TOTAL
EARNINGS |
2056.047 |
1833.710 |
1235.200 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw / Packing materials |
896.649 |
677.766 |
502.862 |
|
|
Capital Goods |
0.151 |
3.873 |
3.407 |
|
|
TOTAL
IMPORTS |
896.800 |
681.639 |
506.269 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (Rs.) |
4.36 |
3.09 |
1.58 |
KEY RATIOS
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
|
|
|
|
Net Profit Margin PAT / Sales |
(%) |
5.64
|
4.82 |
3.10 |
|
|
|
|
|
|
|
Operating Profit Margin (PBDIT/Sales) |
(%) |
5.64
|
14.39 |
13.70 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
5.30 |
4.23 |
2.26 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.12 |
0.09 |
0.05 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.80 |
0.73 |
0.82 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.37 |
1.34 |
1.11 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Share Capital |
476.289 |
476.289 |
476.289 |
|
Reserves & Surplus |
684.192 |
804.822 |
975.214 |
|
Net
worth |
1160.481 |
1281.111 |
1451.503 |
|
|
|
|
|
|
long-term borrowings |
645.862 |
694.819 |
632.270 |
|
Short term borrowings |
311.253 |
243.734 |
522.660 |
|
Total
borrowings |
957.115 |
938.553 |
1154.930 |
|
Debt/Equity
ratio |
0.825 |
0.733 |
0.796 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
1989.054 |
2502.192 |
3019.566 |
|
|
|
25.798 |
20.677 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
1989.054 |
2502.192 |
3019.566 |
|
Profit |
61.675 |
120.630 |
170.392 |
|
|
3.10% |
4.82% |
5.64% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
Yes |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director,
if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
Yes |
LITIGATION DETAILS
CASE DETAILS
BENCH:-BOMBAY
|
Lodging No.:- |
ITXAL/676/2011 |
Filing Date:- |
18/05/2011 |
Reg. No.:- |
ITXA/2011/2011 |
Reg. Date:- |
24/08/2011 |
|
Petitioner:- |
THE COMMISSIONER OF INCOME TAX CENTRAL |
Respondent:- |
KOPRAN LIMITED |
|
Petn.Adv.:- |
J.S. SALUJA (0) |
Resp.Adv.:- |
ARVIND RATHOD AND COMPANY |
|
District:- |
MUMBAI |
|
Bench:- |
DIVISION |
||||
|
Status:- |
Admitted(Unready) |
Category:- |
TAX APPEALS |
|
Last Date:- |
26/07/2012 |
Stage:- |
APPEALS FOR ADMISSION – FRESH [ORIGINAL
SIDE MATTERS] |
|
Last Coram:- |
HON'BLE SHRI JUSTICE S.J. VAZIFDAR |
|
HON'BLE SHRI JUSTICE M.S. SANKLECHA |
|
Act :- |
Income Tax Act, 1961 |
|
|
FINANCIAL PERFORMANCE
Standalone
Net revenue from operations on standalone basis increase to Rs.3033.000 Millions as against Rs.2519.400 Millions in the previous year, a growth of 20% . The profit after tax for the current year is Rs.170.400 Millions as against Rs.120.600 Millions in the previous year, a growth of 41%.
MANAGEMENT DISCUSSION
AND ANALYSIS
INDUSTRIAL OVERVIEW
The Indian Pharmaceutical Industry has grown to a size of more than 2 billion dollars, while the Global Pharmaceutical Market is nearly 1.3 trillion dollars. The continuing opportunity in Generics due to products going off patent, offers a huge potential to the Indian Pharmaceutical Industry, especially product development and contract manufacturing.
India continues to be the largest supplier of Generic products to the Regulated markets like US, Europe, Japan and Australia.
FINANCIAL PERFORMANCE
AND REVIEW
During the year, the company achieved a total revenue of Rs.3032.900 Millions.(Previous Year Rs.2519.300 Millions.) and a Profit before Depreciation, Interest and Tax of Rs.439.600 Millions. (Previous Year: Rs. 360.100 Millions.).The Net Profit is Rs.170.400 Millions. (Previous Year: Rs.120.600 Millions.).
There was 41 % increase in profitability of the company during Financial Year 2013-14 in comparison to Previous Year 2012-13. Ratio of domestic and international sales revenue amounted to the ratio of 26:74
UNSECURED LOAN
|
PARTICULARS |
31.03.2014 (Rs.
in Millions) |
31.03.2013 (Rs.
in Millions) |
|
Long-term
Borrowings |
|
|
|
Other |
80.000 |
80.000 |
|
Inter corporate deposits Other |
545.448 |
585.374 |
|
Total |
625.448 |
665.374 |
INDEX
OF CHARGES
|
S.NO. |
CHARGE ID |
DATE OF CHARGE
CREATION/MODIFICATION |
CHARGE AMOUNT
SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST
NUMBER (SRN) |
|
1 |
10470926 |
16/11/2013 |
100,000,000.00 |
PUNJAB NATIONAL BANK |
8/167, READY MONEY TARRACE, DR. A. B. ROAD, WORLI, MUMBAI, MAHARASHTRA - 400018, INDIA |
B93789881 |
|
2 |
10428024 |
29/04/2013 |
110,000,000.00 |
THE FEDERAL BANK LIMITED |
MUMBAI-FORT,32,BOMBAY SAMACHAR MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA |
B75858308 |
|
3 |
10421518 |
30/03/2013 |
90,000,000.00 |
THE FEDERAL BANK LIMITED |
MUMBAI-FORT,32,BOMBAY SAMACHAR MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA |
B73690273 |
|
4 |
10406606 |
28/01/2014 * |
115,000,000.00 |
STATE BANK OF INDIA |
COMMERCIAL BRANCH, N.G.N. VAIDYA MARG, BANK STREET, HORNIMAN CIRCLE, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA |
B96826433 |
|
5 |
10392397 |
20/11/2012 |
30,000,000.00 |
THE FEDERAL BANK LIMITED |
MUMBAI-FORT,32,BOMBAY SAMACHAR MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA |
B64300460 |
|
6 |
10302578 |
07/06/2014 * |
500,000,000.00 |
THE FEDERAL BANK LIMITED |
MUMBAI-FORT,32,BOMBAY SAMACHAR MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA |
C09684903 |
|
7 |
10058570 |
04/07/2007 |
80,000,000.00 |
CANARA BANK |
TAMARIND LANE BR.,
CALCOT HOUSE,, TAMARIND LANE,, |
A18114975 |
|
8 |
90243976 |
10/08/2005 |
26,000,000.00 |
STATE BANK OF INDIA |
COMMERCIAL BR.;G;N; VAIDYA MARG, MUMBAI, MAHARASHTRA - 400001, INDIA |
- |
|
9 |
90223577 |
04/05/2005 |
100,000,000.00 |
UTI BANK LIMITED |
NO.9 MAG ROAD;, BANGALORE, KARNATAKA - 560001, INDIA |
- |
|
10 |
90223225 |
10/08/2005 * |
199,500,000.00 |
THE FEDERAL BANK LTD |
NARIMAN BHAVAN FIRST FLOOR NARIMAN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA |
- |
* Date of charge modification
CONTINGENT
LIABILITIES:
(Rs. in millions)
|
PARTICULAR |
31.03.2014 (Rs. In
Millions) |
31.03.2013 (Rs. In
Millions) |
|
i)
Guarantees given by the company's bankers on behalf of the Company |
16.959 |
11.950 |
|
ii)
Bills discounted with banks |
432.886 |
451.414 |
|
iii)
Disputed tax matters |
|
|
|
a)
Service tax demand disputed in appeal |
3.405 |
3.295 |
|
b)
Excise duty demand disputed in appeal |
3.869 |
4.388 |
|
c)
Demand under drug price control order - 95 ( DPCO – 95 demand disputed in
appeal) |
59.134 |
59.134 |
STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS
FOR THE QUARTER ENDED 30TH SEPTEMBER 2014
(Rs. in millions)
|
Sr. No. |
Particulars |
Quarter Ended |
6 months ended |
|
|
30.09.2014 |
30.06.2014 |
30.09.2014 |
||
|
Unaudited |
Unaudited |
Unaudited |
||
|
Part I |
|
|
|
|
|
1. |
Income from
Operations |
|
|
|
|
|
a)
Net Sales / Income from Operations |
774.900 |
668.900 |
1444.500 |
|
|
b)
Other Operating Income |
19.200 |
14.900 |
33.400 |
|
|
Total
Income from Operations (net) |
794.100 |
683.800 |
1477.900 |
|
2. |
Expenditure |
|
|
|
|
|
a)
Cost of materials consumed |
569.600 |
453.300 |
1022.800 |
|
|
b)
Purchase of stock-in-trade |
4.800 |
4.200 |
9.000 |
|
|
c) Changes in inventories
of finished goods, work-in-progress and stock-in-trade |
(63.000) |
(12.600) |
(75.600) |
|
|
d)
Employee benefits expense |
67.300 |
59.200 |
126.500 |
|
|
e)
Depreciation and amortisation expense |
32.300 |
31.600 |
63.900 |
|
|
f) Power and Fuel Charges |
-- |
-- |
-- |
|
|
g)
Other expenses |
140.100 |
108.000 |
248.200 |
|
|
Total Expenses |
751.100 |
643.700 |
1394.800 |
|
3. |
Profit/ (Loss) from
Operations before Other Income, Exchange gain/(loss), Finance costs and Exceptional
items (1-2) |
43.000 |
40.100 |
83.100 |
|
4a. |
Other Income |
4.500 |
3.000 |
2.000 |
|
4b. |
Exchange
Gain / (Loss) (Net) |
13.800 |
19.100 |
32.900 |
|
5. |
Profit /(Loss) from
Ordinary activities before finance costs and Exceptional items (3+4a+4b) |
61.300 |
59.500 |
120.800 |
|
6. |
Finance Costs |
30.400 |
29.200 |
37.500 |
|
7. |
Profit / (Loss) from ordinary activities
after Finance costs but before Exceptional items (5-6) |
30.900 |
30.300 |
61.200 |
|
8. |
Exceptional items |
-- |
-- |
-- |
|
9. |
Profit/ (Loss) from ordinary activities
before tax (7+8) |
30.900 |
30.300 |
61.200 |
|
10. |
Tax expenses |
-- |
-- |
-- |
|
11. |
Net Profit / (Loss) from ordinary
activities after tax (9-10) |
30.900 |
30.300 |
61.200 |
|
12. |
Extraordinary
items |
-- |
-- |
-- |
|
13. |
Net Profit /
(Loss) for the period (11+12) |
|
|
|
|
14. |
Paid-up equity share capital (Face Value of Rs. 10 per share) |
390.500 |
390.500 |
390.500 |
|
15. |
Reserve excluding Revaluation reserve |
-- |
-- |
-- |
|
16. |
Earnings Per Share (EPS) before and after extraordinary items (of Rs.
10/- each) a) Basic b) Diluted |
0.79 0.79 |
0.78 0.78 |
1.57 1.57 |
|
|
|
|
|
|
|
Part II |
|
|
|
|
|
A. |
PARTIULARS OF SHAREHOLDINGS |
|
|
|
|
|
Public
Shareholding |
|
|
|
|
|
- Number of Shares |
23753463 |
23753463 |
23753463 |
|
|
- Percentage of Shareholding |
60.83% |
60.83% |
60.83% |
|
|
Promoters and
Promoter Group Shareholding |
|
|
|
|
|
a)
Pledged/Encumbered |
|
|
|
|
|
- Number of Shares |
3352500 |
3352500 |
3352500 |
|
|
- Percentage of Shares (as a % of the Total Shareholding of promoter
and promoter group) |
21.92% |
21.92% |
21.92% |
|
|
- Percentage of Shares (as a % of the Total Share Capital of the
Company) |
8.59% |
8.59% |
8.59% |
|
|
b) Non
Encumbered |
|
|
|
|
|
- Number of Shares |
11943513 |
11943513 |
11943513 |
|
|
- Percentage of Shares (as a % of the Total Shareholding of Promoter
and Promoter Group) |
78.08% |
78.08% |
78.08% |
|
|
- Percentage of Shares (as a % of the Total Share Capital of the
Company) |
30.58% |
30.58% |
30.58% |
|
PARTICULARS |
For the quarter ended 30th SEPTEMBER
2014 |
|
B INVESTORS COMPLAINTS |
|
|
Pending at the beginning of the quarter |
Nil |
|
Received during the quarter |
21 |
|
Disposed during the quarter |
21 |
|
Remaining unresolved at the end of the quarter |
Nil |
SEGMENT WISE REVENUE, RESULTS AND CAPITAL
EMPLOYED
FOR THE QUARTER ENDED 30TH
SEPTEMBER 2014
(Rs. in millions)
|
Sr. No. |
Particulars |
Quarter Ended |
Quarter Ended |
Six Months Ended |
|
30.09.2014 |
30.06.2014 |
30.09.2014 |
||
|
|
|
Unaudited |
||
|
A |
Segment Revenue |
|
|
|
|
|
a)
Pharmaceutical |
806.400 |
698.500 |
1503.300 |
|
|
b)
Consumer Care Division |
6.500 |
6.100 |
12.600 |
|
|
Total |
812.900 |
704.600 |
1515.900 |
|
|
|
|
|
|
|
Less: |
Inter-Segment Revenue |
-- |
-- |
-- |
|
Less: |
Excise duty |
18.800 |
20.800 |
38.000 |
|
|
Net Sales/Income
from Operation |
794.100 |
683.800 |
1477.900 |
|
|
|
|
|
|
|
B |
Segment Results |
|
|
|
|
|
a)
Pharmaceutical |
68.200 |
66.400 |
134.600 |
|
|
b)
Consumer Care Division |
(6.900) |
(6.900) |
(13.800) |
|
|
Total |
61.300 |
59.500 |
120.800 |
|
|
|
|
|
|
|
|
Less:
Finance Cost |
30.400 |
29.200 |
59.600 |
|
|
Total Profit Loss Before Taxation |
30.900 |
30.300 |
61.200 |
|
|
|
|
|
|
|
C |
Capital Employed (Segment
Assets - Segment Liabilities) |
|
|
|
|
|
a)
Pharmaceutical |
2127.000 |
1978.500 |
2127.000 |
|
|
b)
Consumer Care Division |
57.300 |
41.800 |
57.300 |
|
|
c)
Others (Unallocated) |
541.800 |
541.800 |
541.800 |
|
|
Total |
2726.100 |
2562.100 |
2726.100 |
STANDALONE /
CONSOLIDATED STATEMENT OF ASSETS AND LIABILITIES
|
Particulars |
As at 30.09.2014 |
|
|
|
Particulars |
|
|
A |
EQUITY AND
LIABILITIES |
|
|
1 |
Shareholder’s Funds |
|
|
|
a) Share Capital |
476.300 |
|
|
b) Reserves & Surplus |
1036.400 |
|
|
c) Money received against share warrants |
0.000 |
|
|
Sub Total-
Shareholders funds |
1512.700 |
|
2 |
Share application
money pending allotment |
0.000 |
|
3 |
Minority Interest |
0.000 |
|
4 |
Non-current
liabilities |
|
|
|
(a) Long term borrowings |
600.700 |
|
|
(b) Other long term liabilities |
0.000 |
|
|
fc) Long term provisions |
36.500 |
|
|
Sub Total- Non
Current Liabilities |
637.200 |
|
5 |
Current liabilities |
|
|
|
(a) Short term borrowings |
485.100 |
|
|
(b) Trade Payables |
357.200 |
|
|
(c) Other current liabilities |
274.400 |
|
|
(d) Short term provisions |
1.400 |
|
|
Sub Total- Current
Liabilities |
1118.100 |
|
|
TOTAL-EQUITY AND
LIABILITIES |
3268.000 |
|
B |
ASSETS |
|
|
1 |
Non-current assets |
|
|
|
(a) Fixed assets |
990.900 |
|
|
(b) Capital work-in-progress |
13.600 |
|
|
(c) Non-current investment |
68.700 |
|
|
(b) Long term loans and advances |
597.000 |
|
|
Sub-Total- Non
current assets |
1670.200 |
|
2 |
Current assets |
|
|
|
a) Current Investments |
0.000 |
|
|
b) Inventories |
586.300 |
|
|
c) Trade Receivables |
509.700 |
|
|
d) Cash and cash equivalents |
37.100 |
|
|
(e) Short term loans and advances |
464.700 |
|
|
(f) Other current assets |
0.000 |
|
|
Sub-Total- current
assets |
1597.800 |
|
|
TOTAL ASSETS |
3268.000 |
FIXED ASSETS
v
Tangible
Assets
· Lease Hold Land
· Free Hold Land
· Buildings
· Plant and Machinery
· Plant and Machinery
· Tube Well
· Office Equipment’s
· Computers
· Vehicles
PRESS RELEASE
KOPRAN
JUMPS 15% ON SHARES ALLOTMENT TO PROMOTER GROUP CO
Moneycontrol Bureau
Investors lapped up shares of Kopran, the pharmaceutical company manufactures both active pharmaceutical ingredients and finished dosage forms, after it allotted equity shares and warrants worth Rs 27.72 crore to its promoter group company. The stock gained as much as 15 percent intraday Thursday.
The Corporate Affairs Committee of the company, on November 26, has allotted 20,50,000 equity shares of face value Rs 10 at a premium of Rs 56 each and 21,50,000 warrants at Rs 66 each to be converted in equity shares of face value 10 at a premium of Rs 56 to Oricon Properties Private Limited, a promoter group company.
Oricon Properties Private Limited holds 4.51 percent stake in the company, as of September 2014.
At 13:01 hours IST, the stock was quoting at Rs 61.05, up Rs
4.60, or 8.15 percent on the BSE.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 62.15 |
|
|
1 |
Rs. 94.72 |
|
Euro |
1 |
Rs. 70.33 |
INFORMATION DETAILS
|
Information
Gathered by : |
PPT |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
JYO |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILITY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
YES |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.